A specialized researcher focused on advancing longevity science and biotech innovation within Switzerland's leading research ecosystem, developing therapeutic interventions and biotechnologies to extend healthspan and address age‑related diseases. This role combines cutting‑edge molecular biology, gerontology, and translational research to drive breakthrough discoveries in the Swiss biotech sector, which is recognized globally for precision medicine and life sciences excellence.
Company Overview
Biotechnology
Founded 2019
Mission
To extend human healthspan by reversing cellular aging through AI‑integrated epigenetic reprogramming and senolytic discovery.
Values
Ethical AI Stewardship
Radical Transparency
Culture
A high‑performance, hybrid‑first environment blending Swiss precision with Silicon Valley agility, prioritizing ESG‑aligned research practices.
Role Summary
Purpose: Lead high‑throughput longevity screening and validate AI‑generated therapeutic targets for age‑related pathologies.
Impact: Directly influences the development of first‑in‑class rejuvenation therapies while ensuring compliance with the 2026 EU AI Act regulatory framework.
Team Structure
Part of the Translational Geroscience Unit, collaborating with 4 Computational Biologists and 3 Wet‑lab Technicians.
Reports To
VP of Longevity Research.
Working Conditions
Travel Required: 15%
Standard business hours with occasional evening calls for US West Coast collaboration.
Physical Requirements
Ability to perform precision pipetting and microscopy for extended periods.
Comfort working in BSL‑2 laboratory environments.
#J-18808-Ljbffr